HEALTH & LIFE SCIENCES NEWS
HEALTH & LIFE SCIENCES NEWS
Exploring Critical Business and Legal Issues across the Healthcare and Life Sciences Industries
HEALTH & LIFE SCIENCES NEWS
Exploring Critical Business and Legal Issues across the Healthcare and Life Sciences Industries

5 Questions with a Health Lawyer: Tony Maida

Tony Maida
Practice Focus Area: Health
Office: New York
Years at Firm: 6 years

What is your favorite part about practicing healthcare law at McDermott?
The people and the variety. I have to be honest that when I left government service with the HHS Office of Inspector General, I did not expect to find even a similar type of camaraderie at Big Law given the time pressures and demands. I have been pleasantly surprised by how the health group truly functions as a team. People help each other out, whether it is to contribute to a pitch, thought piece, or client project, and do so with enthusiasm. This espirit de corps is an ingrained part of the culture.

And I am happiest when I have variety in my work. At McDermott, I work with clients across the healthcare spectrum, from health systems, physician practices and post-acute providers and suppliers, life sciences and technology companies as well as payors. These clients present many regulatory issues to grapple with and having this broad industry viewpoint helps give the best-informed advice and identify practical solutions.

What is the biggest opportunity and greatest challenge facing clients in your area of focus today?
It is a bit of a cliché to say healthcare is always changing, but sometimes clichés are true. We have a confluence of a few large issues 1) changing payment models in part driven by government budgets and aging population, [...]

Continue Reading




Impact Finance: Innovative Solutions to Target Global Health Issues

As the economic impact of Coronavirus (COVID-19) continues to unfold, demand for healthcare remains a unifying global factor and provides an opportunity for innovative investment models to aid recovery and growth. Between 2020 and 2024, global health spending is expected to rise at a 3.9% compound annual growth rate, considerably faster than the 2.8% recorded in 2015–2019.

Those responsible for buying healthcare services (payors) commonly monitor population health metrics and the impact of changes to the healthcare landscape, such as clean water or vaccination programmes to assess need and allocate resources as part of their mandate.

(more…)




Sovereign Wealth Fund Investment in the Global Healthcare Industry

Sovereign Wealth Funds are state owned entities that are used as an investment vehicle by a state, and where the original investment funds are usually derived from state generated sources. SWFs in turn make investments into a variety of real and financial assets such as stocks, bonds, real estate, commodities, private equity, and other trading arrangements. They invest both in their domestic markets and also increasingly on a global basis, and are important funding and investment sources alongside traditional investors.

SWF: Aims And Objectives

It is important to understand that SWFs have additional aims and objectives, and different characteristics, when compared with other investors. These manifest themselves in the way SWFs formulate and adopt their risk policies (including appetites and tolerances), the manner of their investment, their liquidity requirements, the length of their investment timelines and how they organise other priorities.

Occasionally, these priorities can include environmental, social, and corporate governance (ESG) aims. In particular, an SWF may look at the societal benefits of an investment and not just the obvious economic or financial benefits.

Click here to read the full article in our latest International News.




McDermott Earns “Elite” Firm Designation and 12th Consecutive Band 1 National Ranking from Chambers USA

International law firm McDermott Will & Emery is pleased to announce its Healthcare Group received its 12th consecutive national Band 1 ranking in the 2021 edition of Chambers USA. The team also earned Band 1 state-level healthcare rankings in California, Florida, Illinois, Massachusetts and Washington, DC. Additionally, the Firm earned the national Spotlight Table ranking for the Privacy and Data Security: Healthcare category. Overall, the Firm saw a 25% increase in the number of new partners recognized, bringing the total to 37.

Chambers praised McDermott’s Health Industry Advisory practice, describing the team as “top-notch” and “very knowledgeable, responsive and practical.” Interviewees also drew attention to the Firm’s “incredible roster of clients.”

Clients provided similarly impressive remarks, noting our team’s deep bench strength and specialties. “McDermott is the best – they have the deepest knowledge and the most subspecialists” and “the firm consistently produces high-value work. It does a great job quickly analyzing and reporting out on regulatory and legislative changes.” One interviewee recognized “McDermott’s healthcare practice is unparalleled. It has experts on every corner of the industry.”

This year was particularly important and challenging for the health industry. Our passion and dedication to help clients achieve and surpass their business goals, while delivering the highest level of care – no matter the state of the healthcare landscape – was most important to us.  “We are honored that Chambers USA again recognized our unwavering commitment to clients,” said Eric Zimmerman, global lead of McDermott’s Health practice. “After the challenges over the last [...]

Continue Reading




STAY CONNECTED

TOPICS

ARCHIVES